This report highlights the issues surrounding high prices and poor supply of the drugs needed to treat drug-resistant tuberculosis (DR-TB). The report provides an overview of available drug-resistant TB medicines, including drug sources, quality status, and price.
Format:
Report
Publication Date:
2013
ID:
33881
- International Agencies
- Policy Makers
- TB
- Extensively Drug-Resistant TB (XDR TB)
- MDR TB
- TB Treatment
- Treatment- Medication Information
- Treatment- TB Disease